SCHEMBL1824924

SCHEMBL1824924

CCOC(=O)CC(Cc1ccc(OS(C)(=O)=O)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.44
PTPRB P23467 2/20 0.43
ABCB1 P08183 1/20 0.43
PPARG P37231 3/20 0.41
PPARA Q07869 2/20 0.41
TSHR P16473 2/20 0.40
SYK P43405 1/20 0.40
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
BCL2 P10415 1/20 0.39
HTT P42858 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
APP P05067 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825418 0.91 ABCB1 (0.50) ATMABCB1PPARGPPARATSHR
SCHEMBL1823118 0.90 ATM (0.46) ATMPTPRBABCB1PPARGPPARA
SCHEMBL1825241 0.88 ATM (0.51) ATMABCB1PPARGPPARASYK
SCHEMBL1825632 0.87 ATM (0.44) ATMPTPRBABCB1PPARGPPARA
SCHEMBL1824660 0.87 P2RX7 (0.51) ATMPTPRBABCB1BCL2CA2
SCHEMBL1825368 0.87 ABCB1 (0.50) ATMPTPRBABCB1TSHRSYK
SCHEMBL1823397 0.85 ACACB (0.48) PPARGPPARA
SCHEMBL1827412 0.84 ATM (0.49) ATMPTPRBABCB1PPARGPPARA
SCHEMBL1826124 0.84 ITGB3 (0.48) ABCB1PPARGITGB3ITGA2BBCL2
SCHEMBL1826126 0.84 ITGB3 (0.48) ABCB1PPARGITGB3ITGA2BBCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ATM 4601/4885PTPRB 4353/4885ABCB1 1436/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ATM 4386/4885PTPRB 3553/4885ABCB1 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.